Skip to content

Systematic review, 2026

How much of PMDD treatment improvement comes from placebo effect?

The placebo effect accounts for 20.9% to 38.4% of treatment improvement, depending on which symptom is measured. Measuring total symptoms rather than individual symptoms like depression gives more reliable results for testing new treatments.

Strong study design 5406 patients from 47 randomized controlled trials about premenstrual disorders

What they did

A model-based meta-analysis of 47 randomized controlled trials about premenstrual disorders involving 5406 patients. Researchers analyzed how well five common ways of measuring symptoms predict whether a treatment works.

What they found

Five common measurements were identified: total symptom score, depression symptoms, anxiety symptoms, irritability symptoms, and physical symptoms. The maximum placebo response ranged from 20.9% to 38.4%, with improvements reaching their peak within 2 to 3 months. Total symptom score had the smallest placebo response (most reliable measurement) and the quickest response to treatment. The supplement S-equol showed no real benefit beyond placebo.

What it means for you

About one-fifth to one-third of treatment benefit comes from placebo effect. This helps scientists understand whether treatments actually work. Measuring total symptoms gives more reliable results than individual symptoms. This information helps researchers design better studies.

5406

Patients analyzed

47

Randomized controlled trials

20.9% to 38.4%

Placebo response range

About the study

Original title
Quantitative Analysis of Placebo Response Models to Optimize Clinical Trials in Premenstrual Disorders: A Model-Based Meta-analysis
Authors
Yang X, Lv Y, Liu Y et al.
Journal
Biopsychosocial science and medicine
Year
2026
Study design
Systematic review
What was tested
Various medications and supplements for PMDD including S-equol

Topics